Optimization of conditions for transfection with the Sofast gene vector.

We previously reported the synthesis and characterization of a novel cationic polymer gene vector. The present article further explored and optimized the working conditions of the Sofast gene vector both in vitro and in vivo, and improved its performance. The transfection conditions of Sofast, such as cell type, cell density, transfection time, N/P values and analysis time after transfection, were further explored. Moreover, the effects of the fusion peptide diINF-7 on transfection efficiency were examined. Sofast was successfully applied for the transfection of exogenous genes into more than 40 types of cell lines derived from humans, mice, monkeys and other species. When the cells were 50-80% confluent, Sofast possessed a better transfection efficiency. In most cases, Sofast also had a higher transfection efficiency when it was used to transfect cells that were seeded for several hours and had adhered to the substrate. The results from in vitro experiments indicate that the recommended Sofast to DNA mass ratio is 16:1, and the optimum analysis time after transfection is 48 h. The salt concentration in the Sofast working solution markedly affected the transfection efficiency. When conducting in vivo transfection, the working solution should be salt-free, whereas for in vitro transfection, it is more appropriate for the working solution to include certain salt concentrations. Finally, the results confirm that diINF-7 significantly promotes the transfection efficiency of Sofast. In conclusion, the present research not only established the optimal conditions for Sofast in the transfection of commonly used cells, but also built the foundations for in vivo and in vitro applications of Sofast, as well as its use in clinical practice.

[1]  Zuo-Gen Fu,et al.  Development and evaluation of a novel nano‐scale vector for siRNA , 2010, Journal of cellular biochemistry.

[2]  Zuo-Gen Fu,et al.  Synthesis and characterization of a novel cationic polymer gene delivery vector. , 2010, International journal of molecular medicine.

[3]  Kishan Dholakia,et al.  Phototransfection of mammalian cells using femtosecond laser pulses: optimization and applicability to stem cell differentiation. , 2010, Journal of biomedical optics.

[4]  Jie Min,et al.  A role for MHBst167/HBx in hepatitis B virus-induced renal tubular cell apoptosis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Hongbin Wu,et al.  Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin. , 2010, Biochemical and biophysical research communications.

[6]  M. Rekha,et al.  Dextran-glycidyltrimethylammonium chloride conjugate/DNA nanoplex: A potential non-viral and haemocompatible gene delivery system. , 2010, International journal of pharmaceutics.

[7]  Hsing-Wen Sung,et al.  Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. , 2009, Biomaterials.

[8]  W. Jiskoot,et al.  Strategies for cytosolic delivery of liposomal macromolecules. , 2005, International journal of pharmaceutics.

[9]  W. Jiskoot,et al.  Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins* , 2002, The Journal of Biological Chemistry.

[10]  S. Dowdy,et al.  Protein transduction technology. , 2002, Current opinion in biotechnology.

[11]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[12]  E. Wagner,et al.  Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. , 2001, Bioconjugate chemistry.

[13]  I. R. Hill,et al.  Determination of protection from serum nuclease activity by DNA-polyelectrolyte complexes using an electrophoretic method. , 2001, Analytical biochemistry.

[14]  Seymour,et al.  Key issues in non-viral gene delivery. , 2001, Advanced drug delivery reviews.

[15]  Wagner,et al.  Application of membrane-active peptides for nonviral gene delivery. , 1999, Advanced drug delivery reviews.

[16]  A. Mikos,et al.  Poly(ethylenimine) and its role in gene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[17]  K Mechtler,et al.  The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells , 1998, Gene Therapy.

[18]  M. Wolfert,et al.  Chloroquine and amphipathic peptide helices show synergistic transfection in vitro , 1998, Gene Therapy.

[19]  J. Behr,et al.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. , 1996, Gene therapy.

[20]  K Mechtler,et al.  The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. , 1994, The Journal of biological chemistry.

[21]  F. Szoka,et al.  pH-dependent bilayer destabilization by an amphipathic peptide. , 1987, Biochemistry.

[22]  J. H. Kim,et al.  Non-viral gene delivery of DNA polyplexed with nanoparticles transfected into human mesenchymal stem cells. , 2010, Biomaterials.

[23]  K. Büssow,et al.  Transient Production of scFv-Fc Fusion Proteins in Mammalian Cells , 2010 .

[24]  L. Seymour,et al.  Key issues in non-viral gene delivery: Adv Drug Deliv Rev , 1998 .